Valuation: Sanofi

Capitalization 96.83B 114B 89.61B 84.38B 157B 10,572B 160B 1,051B 411B 5,077B 427B 418B 18,088B P/E ratio 2026 *
11.8x
P/E ratio 2027 * 10.7x
Enterprise value 108B 126B 99.5B 93.69B 175B 11,738B 178B 1,167B 457B 5,637B 474B 464B 20,083B EV / Sales 2026 *
2.31x
EV / Sales 2027 * 2.1x
Free-Float
87.31%
Yield 2026 *
5.3%
Yield 2027 * 5.64%
1 day-0.90%
1 week-2.89%
Current month-3.06%
1 month+5.17%
3 months-5.03%
6 months-3.78%
Current year-3.06%
1 week 79.61
Extreme 79.61
83.42
1 month 75.33
Extreme 75.33
83.77
Current year 74.85
Extreme 74.85
84.97
1 year 74.85
Extreme 74.85
98.36
3 years 74.85
Extreme 74.85
110.88
5 years 74.85
Extreme 74.85
110.88
10 years 62.5
Extreme 62.5
110.88
Manager TitleAgeSince
Chief Executive Officer 61 17/02/2026
Director of Finance/CFO 63 01/04/2024
Chief Operating Officer 41 01/10/2023
Director TitleAgeSince
Director/Board Member 72 01/05/2014
Director/Board Member 60 30/04/2019
Director/Board Member 56 28/04/2020
Name Varia. Jan 1. Weight AuM
+2.21%3.66% 158 M€
Change 5d. change 1-year change 3-years change Capi.($)
-0.90%-2.89%-10.52%-21.00% 114B
-1.65%+0.42%+28.27%+158.07% 841B
-1.18%-1.88%+57.16%+45.16% 574B
-2.10%-0.43%+18.79%+28.85% 368B
-0.09%0.00%+30.43%+16.21% 320B
-0.30%-0.56%+52.18%+30.95% 318B
-1.03%+0.46%+53.35%+7.94% 300B
-0.34%-1.17%+41.43%+40.20% 295B
-1.29%+0.89%+22.74%+39.61% 189B
-2.18%-0.52%+34.12%+68.39% 173B
Average -1.11%-0.04%+32.80%+41.44% 349.15B
Weighted average by Cap. -1.17%-0.09%+36.39%+61.75%

Financials

2026 *2027 *
Net sales 46.6B 54.7B 43.13B 40.61B 75.64B 5,088B 77.19B 506B 198B 2,443B 205B 201B 8,705B 49.49B 58.1B 45.8B 43.13B 80.33B 5,403B 81.98B 537B 210B 2,595B 218B 213B 9,245B
Net income 8.64B 10.14B 7.99B 7.52B 14.02B 943B 14.3B 93.75B 36.68B 453B 38.04B 37.23B 1,613B 9.48B 11.13B 8.77B 8.26B 15.38B 1,035B 15.7B 103B 40.26B 497B 41.75B 40.87B 1,770B
Net Debt 10.68B 12.54B 9.88B 9.31B 17.34B 1,166B 17.69B 116B 45.37B 560B 47.05B 46.05B 1,995B 7.06B 8.29B 6.53B 6.15B 11.46B 771B 11.7B 76.66B 30B 370B 31.1B 30.45B 1,319B
Logo Sanofi
Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (81.8%): prescription drugs for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases; - human vaccines (18.2%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas. At the end of 2025, the group had 37 production sites worldwide. Net sales are distributed geographically as follows: France (3.9%), Europe (17.1%), the United States (50.8%), China (6%) and other (22.2%).
Employees
74,846
Date Price Change Volume
10/04/26 80.19 -0.90% 2,027,807
09/04/26 80.92 +0.06% 2,905,738
08/04/26 80.87 +0.45% 4,090,098
07/04/26 80.51 -2.51% 2,477,075
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
80.19EUR
Average target price
96.10EUR
Spread / Average Target
+19.83%

Quarterly revenue - Rate of surprise